pharma · Hypertriglyceridemia · Asthma · GRCE
Grace Therapeutics
News and analysis for Grace Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA HQ
18 Employees
Public company Type
GRCE · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA
- Employees
- 18
- Programs
- 29
- Drugs
- 37
- Patents
- 34
News & analysis
NovaPharmaNews articles mentioning Grace Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Grace Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.